Climate change and parasitic risk to the blood supply

Steven J. Drews is a paid consultant to Roche on malaria. Ines Ushiro-Lumb is a paid consultant to Roche and Grifols on malaria. Evan M. Bloch reports personal fees and non-financial support from Terumo BCT and Abbott Laboratories, outside of the submitted work; Evan M. Bloch is a member of the United States Food and Drug Administration (FDA) Blood Products Advisory Committee. Any views or opinions that are expressed in this manuscript are those of the author's, based on his own scientific expertise and professional judgment; they do not necessarily represent the views of either the Blood Products Advisory Committee or the formal position of FDA, and do not bind or otherwise obligate or commit either Advisory Committee or the Agency to the views expressed. All other authors have no conflicts to declare. Table S1. Impacts of environmental change on pathogens, vectors, and human disease Table S2. How climate change-driven disasters can impact on human-vector-parasite interactions Table S3. Climate change-mediated changes in human behaviors may change the risks of parasitic infection Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.